domingo, 27 de noviembre de 2022

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study - The Lancet Rheumatology

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario